AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionZevin Asset Management Llc
Latest Disclosed Ownership81,849 shares
Latest Disclosed Value $ 17,801,373
Zevin Asset Management Llc reports 0.82% decrease in ownership of 4AB / AbbVie Inc.

On May 7, 2026 - Zevin Asset Management Llc filed a 13F-HR form disclosing ownership of 81,849 shares of AbbVie Inc. (BG:4AB) valued at $17,801,373 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 82,522 shares of AbbVie Inc.. This represents a change in shares of -0.82% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F AbbVie COM 00287Y109 81,849 -673 -0.82 17,801 -5.59 2.4622
2026-02-12 2025-12-31 13F AbbVie COM 00287Y109 82,522 -4,457 -5.12 18,855 94,175.00 2.5283
2025-11-10 2025-09-30 13F AbbVie COM 00287Y109 86,979 -4,663 -5.09 20 17.65 2.9301
2025-08-06 2025-06-30 13F AbbVie COM 00287Y109 91,642 10,144 12.45 17 0.00 2.4474
2025-05-06 2025-03-31 13F AbbVie COM 00287Y109 81,498 -1,193 -1.44 17 21.43 2.7067
2025-02-10 2024-12-31 13F AbbVie COM 00287Y109 82,691 6,668 8.77 15 -6.67 2.1629
2024-11-07 2024-09-30 13F AbbVie COM 00287Y109 76,023 -1,268 -1.64 15 15.38 2.3219
2024-07-29 2024-06-30 13F AbbVie COM 00287Y109 77,291 -4,528 -5.53 13 -7.14 2.1466
2024-05-09 2024-03-31 13F AbbVie COM 00287Y109 81,819 -799 -0.97 15 16.67 2.4780
2024-02-07 2023-12-31 13F AbbVie COM 00287Y109 82,618 -347 -0.42 13 0.00 2.2990
2023-11-07 2023-09-30 13F AbbVie COM 00287Y109 82,965 1,996 2.47 12 20.00 2.4862
2023-08-07 2023-06-30 13F AbbVie COM 00287Y109 80,969 479 0.60 11 -16.67 2.1888
2023-05-05 2023-03-31 13F AbbVie COM 00287Y109 80,490 -2,328 -2.81 13 -7.69 2.6165
2023-02-07 2022-12-31 13F AbbVie COM 00287Y109 82,818 -1,749 -2.07 13 -99.89 2.9070
2022-11-08 2022-09-30 13F AbbVie COM 00287Y109 84,567 2,114 2.56 11,350 -10.13 2.6811
2022-08-08 2022-06-30 13F AbbVie COM 00287Y109 82,453 -3,908 -4.53 12,629 -9.79 2.8485
2022-05-05 2022-03-31 13F AbbVie COM 00287Y109 86,361 -4,475 -4.93 14,000 13.83 2.6802
2022-01-27 2021-12-31 13F AbbVie COM 00287Y109 90,836 1,137 1.27 12,299 27.11 2.2156
2021-11-10 2021-09-30 13F AbbVie COM 00287Y109 89,699 6,603 7.95 9,676 3.38 1.8440
2021-08-09 2021-06-30 13F AbbVie COM 00287Y109 83,096 2,600 3.23 9,360 7.45 1.8617
2021-05-10 2021-03-31 13F AbbVie COM 00287Y109 80,496 2,434 3.12 8,711 4.15 1.9262
2021-02-11 2020-12-31 13F AbbVie COM 00287Y109 78,062 2,965 3.95 8,364 27.15 1.9626
2020-11-04 2020-09-30 13F AbbVie COM 00287Y109 75,097 2,126 2.91 6,578 -8.18 1.7942
2020-08-06 2020-06-30 13F AbbVie COM 00287Y109 72,971 227 0.31 7,164 29.27 2.1765
2020-05-07 2020-03-31 13F AbbVie COM 00287Y109 72,744 2,999 4.30 5,542 -10.25 2.0622
2020-02-06 2019-12-31 13F AbbVie COM 00287Y109 69,745 354 0.51 6,175 17.53 1.8937
2019-11-05 2019-09-30 13F AbbVie COM 00287Y109 69,391 871 1.27 5,254 5.44 1.6923
2019-08-06 2019-06-30 13F AbbVie COM 00287Y109 68,520 279 0.41 4,983 -9.40 1.6033
2019-04-29 2019-03-31 13F AbbVie COM 00287Y109 68,241 -165 -0.24 5,500 -12.78 1.7965
2019-02-05 2018-12-31 13F AbbVie COM 00287Y109 68,406 -1,782 -2.54 6,306 -5.00 2.2872
2018-11-05 2018-09-30 13F AbbVie COM 00287Y109 70,188 -1,965 -2.72 6,638 -0.70 1.9377
2018-08-08 2018-06-30 13F AbbVie COM 00287Y109 72,153 -12,892 -15.16 6,685 -16.96 1.9954
2018-04-30 2018-03-31 13F AbbVie COM 00287Y109 85,045 -20,180 -19.18 8,050 -20.89 2.0893
2018-02-05 2017-12-31 13F AbbVie COM 00287Y109 105,225 -4,203 -3.84 10,176 4.65 2.3109
2017-10-30 2017-09-30 13F AbbVie COM 00287Y109 109,428 924 0.85 9,724 23.59 2.2846
2017-08-08 2017-06-30 13F AbbVie COM 00287Y109 108,504 -4,440 -3.93 7,868 6.92 1.9860
2017-05-05 2017-03-31 13F AbbVie COM 00287Y109 112,944 -12,239 -9.78 7,359 -6.12 1.8623
2017-02-17 2016-12-31 13F AbbVie COM 00287Y109 125,183 -26,993 -17.74 7,839 -18.33 2.0455
2016-11-07 2016-09-30 13F AbbVie COM 00287Y109 152,176 -20,483 -11.86 9,598 -10.21 3.0958
2016-08-08 2016-06-30 13F AbbVie COM 00287Y109 172,659 1,388 0.81 10,689 9.26 2.9665
2016-05-02 2016-03-31 13F AbbVie COM 00287Y109 171,271 -113,210 -39.80 9,783 -41.95 2.7703
2016-02-08 2015-12-31 13F AbbVie COM 00287Y109 284,481 208,435 274.09 16,853 307.27 4.4388
2015-11-12 2015-09-30 13F AbbVie COM 00287Y109 76,046 -580 -0.76 4,138 -19.63 1.2087
2015-08-05 2015-06-30 13F AbbVie COM 00287Y109 76,626 540 0.71 5,149 15.60 1.3738
2015-05-07 2015-03-31 13F AbbVie COM 00287Y109 76,086 8,100 11.91 4,454 0.11 1.2283
2015-02-10 2014-12-31 13F AbbVie COM 00287Y109 67,986 -8,530 -11.15 4,449 0.66 1.2499
2014-11-06 2014-09-30 13F AbbVie COM 00287Y109 76,516 -33 -0.04 4,420 2.31 1.2942
2014-08-11 2014-06-30 13F AbbVie COM 00287Y109 76,549 13,425 21.27 4,320 33.13 1.2708
2014-05-13 2014-03-31 13F AbbVie COM 00287Y109 63,124 -37,984 -37.57 3,245 -39.22 1.0233
2014-02-10 2013-12-31 13F AbbVie COM 00287Y109 101,108 1,682 1.69 5,339 20.06 1.5086
2013-11-12 2013-09-30 13F AbbVie COM 00287Y109 99,426 99,426 4,447 1.3615
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.